Jennison Associates
EPZM

Jennison Associates’s Epizyme, Inc EPZM Stock Holding History

Jennison Associates’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,309
Closed -$377K – 728
2019
Q4 		$377K Buy
+15,309
New +$227K ﹤0.01% 607
2019
Q2 		– Sell
-710,156
Closed -$8.8M – 685
2019
Q1 		$8.8M Sell
710,156
-1,166,839
-62% -$13M 0.01% 437
2018
Q4 		$11.6M Sell
1,876,995
-324,042
-15% -$2.47M 0.01% 419
2018
Q3 		$23.3M Buy
2,201,037
+16,249
+0.7% +$185K 0.02% 374
2018
Q2 		$29.6M Buy
2,184,788
+36,762
+2% +$572K 0.03% 346
2018
Q1 		$38.1M Buy
2,148,026
+272,498
+15% +$4.6M 0.04% 293
2017
Q4 		$23.5M Buy
1,875,528
+7,867
+0.4% +$114K 0.02% 373
2017
Q3 		$35.6M Sell
1,867,661
-9,474
-0.5% -$145K 0.04% 316
2017
Q2 		$28.3M Sell
1,877,135
-56,669
-3% -$857K 0.03% 348
2017
Q1 		$33.2M Hold
1,933,804
– – 0.04% 340
2016
Q4 		$23.4M Buy
1,933,804
+184,069
+11% +$1.92M 0.03% 393
2016
Q3 		$17.2M Sell
1,749,735
-28,940
-2% -$264K 0.02% 432
2016
Q2 		$18.2M Buy
1,778,675
+12,863
+0.7% +$143K 0.02% 411
2016
Q1 		$21.4M Buy
1,765,812
+871,899
+98% +$8.82M 0.02% 396
2015
Q4 		$14.3M Buy
893,913
+640,245
+252% +$9.49M 0.01% 455
2015
Q3 		$3.26M Buy
253,668
+1,551
+0.6% +$31.3K ﹤0.01% 565
2015
Q2 		$6.05M Buy
252,117
+1,979
+0.8% +$38.1K 0.01% 532
2015
Q1 		$4.7M Buy
+250,138
New +$5.17M ﹤0.01% 524

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Jennison Associates's EPZM Position: Q1 2020 in Review

Jennison Associates sold out of Epizyme, Inc (EPZM) in Q1 2020, closing a stake of 15,309 shares — an estimated $377K sold.

Jennison Associates first reported a position in EPZM in Q1 2015 and held it in 18 quarters. The position peaked at $38.1M in Q1 2018. 143 funds tracked by Wall St. Rank hold EPZM as of Q1 2020.

  • Jennison Associates reported no remaining Epizyme, Inc position as of Q1 2020 after selling out during the quarter.
  • Jennison Associates sold 15,309 Epizyme, Inc shares in Q1 2020, an estimated $377K.
  • Jennison Associates first reported a position in Epizyme, Inc in Q1 2015 and held it in 18 quarters.
  • Jennison Associates's Epizyme, Inc position peaked at $38.1M in Q1 2018.
  • 143 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2020.

Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.